List of Tables
    Table 1. Chronic Urticaria Or Hives Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Chronic Urticaria Or Hives Drug Market Trends
    Table 3. Chronic Urticaria Or Hives Drug Market Drivers
    Table 4. Chronic Urticaria Or Hives Drug Market Challenges
    Table 5. Chronic Urticaria Or Hives Drug Market Restraints
    Table 6. Global Chronic Urticaria Or Hives Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Chronic Urticaria Or Hives Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Chronic Urticaria Or Hives Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Chronic Urticaria Or Hives Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Chronic Urticaria Or Hives Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Chronic Urticaria Or Hives Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Chronic Urticaria Or Hives Drug Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Chronic Urticaria Or Hives Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Chronic Urticaria Or Hives Drug Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Chronic Urticaria Or Hives Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Chronic Urticaria Or Hives Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2021)
    Table 18. Top Players of Chronic Urticaria Or Hives Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Chronic Urticaria Or Hives Drug Product Type
    Table 20. Date of International Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Chronic Urticaria Or Hives Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Chronic Urticaria Or Hives Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Chronic Urticaria Or Hives Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Chronic Urticaria Or Hives Drug Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Chronic Urticaria Or Hives Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Chronic Urticaria Or Hives Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Chronic Urticaria Or Hives Drug Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Chronic Urticaria Or Hives Drug Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Chronic Urticaria Or Hives Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Chronic Urticaria Or Hives Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Chronic Urticaria Or Hives Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Chronic Urticaria Or Hives Drug Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Chronic Urticaria Or Hives Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Chronic Urticaria Or Hives Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Chronic Urticaria Or Hives Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Chronic Urticaria Or Hives Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Plc Corporation Information
    Table 43. AstraZeneca Plc Description and Business Overview
    Table 44. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product
    Table 46. AstraZeneca Plc Recent Development
    Table 47. Biofrontera AG Corporation Information
    Table 48. Biofrontera AG Description and Business Overview
    Table 49. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Biofrontera AG Product
    Table 51. Biofrontera AG Recent Development
    Table 52. ELORAC, Inc. Corporation Information
    Table 53. ELORAC, Inc. Description and Business Overview
    Table 54. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. ELORAC, Inc. Product
    Table 56. ELORAC, Inc. Recent Development
    Table 57. Faes Farma, SA Corporation Information
    Table 58. Faes Farma, SA Description and Business Overview
    Table 59. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Faes Farma, SA Product
    Table 61. Faes Farma, SA Recent Development
    Table 62. Genentech, Inc. Corporation Information
    Table 63. Genentech, Inc. Description and Business Overview
    Table 64. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Genentech, Inc. Product
    Table 66. Genentech, Inc. Recent Development
    Table 67. GlaxoSmithKline Plc Corporation Information
    Table 68. GlaxoSmithKline Plc Description and Business Overview
    Table 69. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. GlaxoSmithKline Plc Product
    Table 71. GlaxoSmithKline Plc Recent Development
    Table 72. J Uriach Y Compania, S.A. Corporation Information
    Table 73. J Uriach Y Compania, S.A. Description and Business Overview
    Table 74. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. J Uriach Y Compania, S.A. Product
    Table 76. J Uriach Y Compania, S.A. Recent Development
    Table 77. Mabtech Limited Corporation Information
    Table 78. Mabtech Limited Description and Business Overview
    Table 79. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Mabtech Limited Product
    Table 81. Mabtech Limited Recent Development
    Table 82. Merck & Co., Inc. Corporation Information
    Table 83. Merck & Co., Inc. Description and Business Overview
    Table 84. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Merck & Co., Inc. Product
    Table 86. Merck & Co., Inc. Recent Development
    Table 87. Mycenax Biotech Inc. Corporation Information
    Table 88. Mycenax Biotech Inc. Description and Business Overview
    Table 89. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Mycenax Biotech Inc. Product
    Table 91. Mycenax Biotech Inc. Recent Development
    Table 92. Novartis AG Corporation Information
    Table 93. Novartis AG Description and Business Overview
    Table 94. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Novartis AG Product
    Table 96. Novartis AG Recent Development
    Table 97. Panacea Biotec Limited Corporation Information
    Table 98. Panacea Biotec Limited Description and Business Overview
    Table 99. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Panacea Biotec Limited Product
    Table 101. Panacea Biotec Limited Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Chronic Urticaria Or Hives Drug Customers List
    Table 105. Chronic Urticaria Or Hives Drug Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chronic Urticaria Or Hives Drug Product Picture
    Figure 2. Global Chronic Urticaria Or Hives Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Chronic Urticaria Or Hives Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Chronic Urticaria Or Hives Drug Sales 2017-2028 (K Pcs)
    Figure 5. United States Chronic Urticaria Or Hives Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Chronic Urticaria Or Hives Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Chronic Urticaria Or Hives Drug Sales 2017-2028 (K Pcs)
    Figure 8. United States Chronic Urticaria Or Hives Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Chronic Urticaria Or Hives Drug Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Chronic Urticaria Or Hives Drug Report Years Considered
    Figure 11. Product Picture of GDC-0853
    Figure 12. Product Picture of GSK-2646264
    Figure 13. Product Picture of BF-Derm-1
    Figure 14. Product Picture of Bilastine
    Figure 15. Product Picture of Others
    Figure 16. Global Chronic Urticaria Or Hives Drug Market Share by Type in 2022 & 2028
    Figure 17. Global Chronic Urticaria Or Hives Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Chronic Urticaria Or Hives Drug Sales by Type (2017-2028) & (K Pcs)
    Figure 20. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Chronic Urticaria Or Hives Drug Price by Type (2017-2028) & (USD/Pcs)
    Figure 22. United States Chronic Urticaria Or Hives Drug Market Share by Type in 2022 & 2028
    Figure 23. United States Chronic Urticaria Or Hives Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Chronic Urticaria Or Hives Drug Sales by Type (2017-2028) & (K Pcs)
    Figure 26. United States Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Chronic Urticaria Or Hives Drug Price by Type (2017-2028) & (USD/Pcs)
    Figure 28. Product Picture of Clinic
    Figure 29. Product Picture of Hospital
    Figure 30. Product Picture of Others
    Figure 31. Global Chronic Urticaria Or Hives Drug Market Share by Application in 2022 & 2028
    Figure 32. Global Chronic Urticaria Or Hives Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Chronic Urticaria Or Hives Drug Sales by Application (2017-2028) & (K Pcs)
    Figure 35. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Chronic Urticaria Or Hives Drug Price by Application (2017-2028) & (USD/Pcs)
    Figure 37. United States Chronic Urticaria Or Hives Drug Market Share by Application in 2022 & 2028
    Figure 38. United States Chronic Urticaria Or Hives Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Chronic Urticaria Or Hives Drug Sales by Application (2017-2028) & (K Pcs)
    Figure 41. United States Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Chronic Urticaria Or Hives Drug Price by Application (2017-2028) & (USD/Pcs)
    Figure 43. North America Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. North America Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. Europe Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 55. Asia-Pacific Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 67. Latin America Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 72. Middle East & Africa Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Chronic Urticaria Or Hives Drug Value Chain
    Figure 77. Chronic Urticaria Or Hives Drug Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed